Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Genmab A/S
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026
October 13, 2026
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
October 5, 2026
Major Shareholder Announcement
October 2, 2026
Genmab Announces Financial Results for the First Half of 2026
August 6, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
July 15, 2026
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
June 29, 2026
Major Shareholder Announcement
June 15, 2026
Major Shareholder Announcement
May 8, 2026
Genmab Announces Financial Results for the First Quarter of 2026
May 7, 2026